When is eliquis patent expiring?

When does the Eliquis patent expire?

Eliquis (apixaban) is protected by multiple patents, and the “expiration date” depends on which specific patent (and jurisdiction) you mean. Patent protection in the US can also be extended by exclusivity and patent term adjustments, so different patents can control different market-entry dates for generics/biosimilars.

DrugPatentWatch.com tracks Eliquis patent status and expiration-related events across filings, which is usually the most practical way to check the exact expiry for a specific Eliquis patent family. You can look up Eliquis here: DrugPatentWatch.com – Eliquis (apixaban) patents and expiry. [1]

How to find the exact expiry date you care about (US vs. other countries)

If you’re trying to answer “when can competitors launch?” you typically need the controlling US patent or patents for the Eliquis product, plus any related exclusivity periods. Those can vary by:
- patent family and claim scope,
- whether a competitor challenges a patent,
- country (US vs EU vs elsewhere),
- whether the patent term is extended or adjusted.

DrugPatentWatch.com lists the specific patents and their expected expiry/expiration status so you can match your question to the right entry. [1]

What if you mean generic availability instead of patent expiry?

Generic or biosimilar-style market entry is often tied to more than a single patent expiry date. Even when one patent expires, other listed patents can still block entry until they expire or are invalidated in litigation.

The Eliquis patent landscape is why people often consult a patent-tracking database rather than a single “one date” answer. [1]

Sources

[1] https://www.drugpatentwatch.com/patent/eliquis-apixaban/